Item 5.03  Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
On June 2, 2021, Biogen Inc. (the "Company") held its 2021 Annual Meeting of
Stockholders (the "Annual Meeting"). At the Annual Meeting, the Company's
stockholders approved and adopted a Certificate of Amendment (the "Certificate
of Amendment") of the Company's Amended and Restated Certificate of
Incorporation, as amended, to add a federal forum selection provision.
The Certificate of Amendment had previously been approved, subject to
stockholder approval, by the Company's Board of Directors.
A detailed discussion of the Certificate of Amendment is set forth in the
Company's definitive proxy statement on Schedule 14A filed with the U.S.
Securities and Exchange Commission on April 23, 2021 (the "Proxy Statement") and
a copy thereof is filed as Exhibit 3.1 hereto and is incorporated herein by
reference.

Item 5.07 Submission of Matters to a Vote of Security Holders. On June 2, 2021, the Company held its Annual Meeting. The final voting results for the Annual Meeting are as follows:



1.Stockholders elected thirteen nominees to the Board of Directors to serve for
a one-year term extending until the 2022 annual meeting of stockholders and
their successors are duly elected and qualified, with the votes cast as follows:
Nominee                                         Votes For                  Votes Against                Abstentions                Broker Non-Votes
Alexander J. Denner                             85,324,257                  34,751,992                     198,427                    10,880,432
Caroline D. Dorsa                               98,819,920                  21,275,514                     179,242                    10,880,432
Maria C. Freire                                102,423,484                  17,668,982                     182,210                    10,880,432
William A. Hawkins                             102,601,625                  17,449,106                     223,945                    10,880,432
William D. Jones                               102,203,806                  17,915,695                     155,175                    10,880,432
Nancy L. Leaming                                99,406,303                  20,752,629                     115,744                    10,880,432
Jesus B. Mantas                                101,944,487                  18,188,895                     141,294                    10,880,432
Richard C. Mulligan                             98,651,559                  21,476,216                     146,901                    10,880,432
Stelios Papadopoulos                            87,157,129                  32,432,277                     685,270                    10,880,432
Brian S. Posner                                 97,506,775                  22,559,655                     208,246                    10,880,432
Eric K. Rowinsky                                79,563,772                  40,575,162                     135,742                    10,880,432
Stephen A. Sherwin                             100,417,717                  19,705,006                     151,953                    10,880,432
Michel Vounatsos                               101,525,313                  18,635,486                     113,877                    10,880,432

2.Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021, with the votes cast as follows:


              Votes For        Votes Against       Abstentions        Broker Non-Votes
             129,131,951         1,889,233           133,924                 -



3.Stockholders approved the advisory vote on executive compensation, with the
votes cast as follows:
             Votes For        Votes Against       Abstentions        Broker Non-Votes
             59,401,387        56,206,071          4,667,218            10,880,432

4.Stockholders approved the amendment to Biogen's Amended and Restate Certificate of Incorporation, with the votes cast as follows:

--------------------------------------------------------------------------------



              Votes For        Votes Against       Abstentions        Broker Non-Votes
             106,341,789        13,671,058           261,829             10,880,432

5.Stockholders rejected the stockholder proposal requesting a report on Biogen's lobbying activities, with the votes cast as follows:


             Votes For        Votes Against       Abstentions        Broker Non-Votes
             49,062,108        70,842,236           370,332             10,880,432

6.Stockholders rejected the stockholder proposal requesting a report on Biogen's gender pay gap, with the votes cast as follows:


             Votes For        Votes Against       Abstentions        Broker Non-Votes
             27,409,376        91,923,643           941,657             10,880,432


Item 9.01   Financial Statements and Exhibits.
(d)  Exhibits
Exhibit No.                    Description
                    3.1          Certificate of Amendment of Biogen Inc.'s Amended and Restated
                               Certificate of Incorporation, as amended.
                    104        Cover Page Interactive Data File (embedded within the Inline XBRL
                               document)




--------------------------------------------------------------------------------


                                   Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Biogen Inc.
By: /s/ Suzanne Murray
Suzanne Murray
Assistant Secretary

Date: June 8, 2021

© Edgar Online, source Glimpses